AMCP Nexus Presentations co-authored by STATinMED

ESPE Accepts Rare Disease Abstract

by | Aug 5, 2023 | News & Events

An abstract co-authored by STATinMED was accepted for presentation at the European Society for Paediatric Endocrinology (ESPE) in Hague, Netherlands, held Sept 21-23, 2023 Dose-dependent risks of glucocorticoid treatment in classic congenital adrenal hyperplasia Click...
AMCP Nexus Presentations co-authored by STATinMED

STATinMED Poster @SOHO

by | Jul 31, 2023 | News & Events

An abstract co-authored by STATinMED was accepted for presentation at the Annual Meeting of the Society of Hematologic Oncology (SOHO) in Houston, TX: Sept 6-9, 2023. Wednesday, September 6th at 6PM Healthcare Resource Utilization and Costs Among Patients With...
Real-world treatment outcomes, healthcare resource use, and costs associated with antiemetics among cancer patients on cisplatin-based chemotherapy

Real-world treatment outcomes, healthcare resource use, and costs associated with antiemetics among cancer patients on cisplatin-based chemotherapy

by | May 31, 2023 | Cancer (blood), Cancer (solid tumor), Publication

ABSTRACT Introduction: Chemotherapy-induced nausea and vomiting (CINV) is a recognized adverse outcome among patients with cancer. This retrospective study aimed to quantify the treatment outcomes, resource utilization, and costs associated with antiemetic use to...